CHAPEL HILL, N.C. – A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for ...

For most patients with active LN, six months of modern effective therapy will improve markers of disease activity, including anti-DNA antibody levels, serum complement, GFR, and degree of hematuria ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Patients with non-renal systemic lupus erythematosus who receive belimumab demonstrate a lower ...

Because lupus can cause a lot of different health problems, there are many different kinds of medicines that can treat it. You and your doctors can work together to find the right combination of ...

Mycophenolate mofetil (MMF) has mainly been used to treat lupus nephritis. Recent studies, however, have shown that MMF could be a safe and effective alternative therapy for patients with systemic ...

Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune disease, in which damage is caused to multiple organs and tissues by the formation and deposition of immune complexes (antigen ...

Prenatal exposure to hydroxychloroquine in birthing parents with systemic lupus erythematosus results in no significant adverse outcomes in children from breast feeding through 17 years, according to ...

Background A 41-year-old, previously healthy woman presented with chest pain, fevers, arthritis, facial rash, pericarditis, proteinuria and a positive antinuclear antibody; she was diagnosed with ...

In a competing-risk analysis involving over 1,400 such patients starting on azathioprine, those who carried the CC genotype of variant rs2814778 – known to be more common among Black individuals – had ...